DE60225834D1 - Antibiotika-ge-81112-faktoren a, b, b1, pharmazeutisch unbedenkliche salze und zusammensetzungen sowie verwendungen davon - Google Patents

Antibiotika-ge-81112-faktoren a, b, b1, pharmazeutisch unbedenkliche salze und zusammensetzungen sowie verwendungen davon

Info

Publication number
DE60225834D1
DE60225834D1 DE60225834T DE60225834T DE60225834D1 DE 60225834 D1 DE60225834 D1 DE 60225834D1 DE 60225834 T DE60225834 T DE 60225834T DE 60225834 T DE60225834 T DE 60225834T DE 60225834 D1 DE60225834 D1 DE 60225834D1
Authority
DE
Germany
Prior art keywords
compositions
salts
factor
pharmaceuticalally
antibiotics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60225834T
Other languages
English (en)
Other versions
DE60225834T2 (de
Inventor
Enrico Selva
Flavia Marinelli
Daniele Losi
Linda Cavaletti
Ameriga Lazzarini
Alessandra Marazzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vicuron Pharmaceuticals LLC
Original Assignee
Vicuron Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vicuron Pharmaceuticals LLC filed Critical Vicuron Pharmaceuticals LLC
Application granted granted Critical
Publication of DE60225834D1 publication Critical patent/DE60225834D1/de
Publication of DE60225834T2 publication Critical patent/DE60225834T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
DE60225834T 2001-11-28 2002-10-04 Antibiotika-ge-81112-faktoren a, b, b1, pharmazeutisch unbedenkliche salze und zusammensetzungen sowie verwendungen davon Expired - Lifetime DE60225834T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01128204 2001-11-28
EP01128204 2001-11-28
PCT/EP2002/011113 WO2003046192A1 (en) 2001-11-28 2002-10-04 Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof

Publications (2)

Publication Number Publication Date
DE60225834D1 true DE60225834D1 (de) 2008-05-08
DE60225834T2 DE60225834T2 (de) 2009-04-09

Family

ID=8179366

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60225834T Expired - Lifetime DE60225834T2 (de) 2001-11-28 2002-10-04 Antibiotika-ge-81112-faktoren a, b, b1, pharmazeutisch unbedenkliche salze und zusammensetzungen sowie verwendungen davon

Country Status (22)

Country Link
US (3) US7407654B2 (de)
EP (1) EP1448784B1 (de)
JP (1) JP4452505B2 (de)
KR (1) KR20040099257A (de)
CN (1) CN1596312A (de)
AT (1) ATE390490T1 (de)
AU (2) AU2002365433A1 (de)
BR (1) BR0214494A (de)
CA (1) CA2468400A1 (de)
DE (1) DE60225834T2 (de)
ES (1) ES2299635T3 (de)
HR (1) HRP20040471A2 (de)
HU (1) HUP0402383A3 (de)
IL (1) IL161896A0 (de)
MX (1) MXPA04005032A (de)
NO (1) NO20042181L (de)
NZ (1) NZ533732A (de)
PL (1) PL370451A1 (de)
RU (1) RU2004119432A (de)
WO (1) WO2003046192A1 (de)
YU (1) YU46804A (de)
ZA (1) ZA200403675B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1596312A (zh) * 2001-11-28 2005-03-16 维库罗恩医药品公司 抗生素ge81112因子a、b、b1、药物可接受的盐和组合物、及其用途
BR112020000196A2 (pt) 2017-07-07 2020-07-07 Epicentrx, Inc. composições para administração parenteral de agentes terapêuticos
KR102408301B1 (ko) * 2020-03-16 2022-06-10 강원대학교산학협력단 항균 활성을 갖는 신균주 스트렙토마이세스 sbc-4 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043353A (en) 1989-10-10 1991-08-27 Eli Lilly And Company A80789 polyether antibiotic
EP0675900B1 (de) 1992-12-22 1998-02-18 Biosearch Italia S.p.A. Die antibiotika ge 37468 a, b und c
US5432193A (en) * 1993-05-14 1995-07-11 American Cyanamid Company Antibiotic LL-D37187α
US5426108A (en) * 1993-11-10 1995-06-20 American Cyanamid Company Antibiotic 31F508 ALPHA1, ALPHA2, BETA1 and BETA2
US5486630A (en) 1994-09-14 1996-01-23 Cheil Foods & Chemicals Inc. Legionella specific antibiotic
CN1596312A (zh) * 2001-11-28 2005-03-16 维库罗恩医药品公司 抗生素ge81112因子a、b、b1、药物可接受的盐和组合物、及其用途

Also Published As

Publication number Publication date
DE60225834T2 (de) 2009-04-09
MXPA04005032A (es) 2004-08-11
RU2004119432A (ru) 2006-01-10
US8007789B2 (en) 2011-08-30
CN1596312A (zh) 2005-03-16
PL370451A1 (en) 2005-05-30
HRP20040471A2 (en) 2004-10-31
NO20042181L (no) 2004-08-04
BR0214494A (pt) 2004-10-19
KR20040099257A (ko) 2004-11-26
IL161896A0 (en) 2005-11-20
JP4452505B2 (ja) 2010-04-21
AU2002365433A1 (en) 2003-06-10
ATE390490T1 (de) 2008-04-15
ZA200403675B (en) 2005-05-13
CA2468400A1 (en) 2003-06-05
YU46804A (sh) 2006-08-17
ES2299635T3 (es) 2008-06-01
AU2008255202A1 (en) 2009-01-08
WO2003046192A1 (en) 2003-06-05
EP1448784A1 (de) 2004-08-25
US20110286996A1 (en) 2011-11-24
US20090023665A1 (en) 2009-01-22
US20050020514A1 (en) 2005-01-27
HUP0402383A3 (en) 2008-03-28
JP2005510573A (ja) 2005-04-21
HUP0402383A2 (hu) 2005-02-28
EP1448784B1 (de) 2008-03-26
NZ533732A (en) 2005-05-27
US7407654B2 (en) 2008-08-05

Similar Documents

Publication Publication Date Title
EP2279662A3 (de) 5,7.4'-trihydroxy-3',5'-dimethoxyflavon als antibakterielles Mittel
HRP20060277A2 (en) 6-0-supstituted ketolides having antibacterial activity
AU2001278003A1 (en) Bacteriophage having multiple host range
RU2009125184A (ru) Композиции, наборы и их применения для защиты кожи от патогенных микроорганизмов
DE60332101D1 (de) Antimikrobielle zusammensetzung
BRPI0213063B8 (pt) composto antibiótico de ação dupla, sua composição farmacêutica e seu uso
WO2005000878A3 (en) Compositions of lipopeptide antibiotic derivatives and methods of use thereof
WO2004041209A3 (en) Transcription factor modulating compounds and methods of use thereof
MXPA05002307A (es) Composiciones antimicrobianas.
MA28613B1 (fr) Macrocycles d'amide antibacteriens
RS20050931A (en) Novel lincomycin derivatives possessing antimicro bial activity
WO2004016632A3 (en) Lincomycin derivatives possessing antibacterial activity
AR029544A1 (es) Composiciones y metodos para tratar infecciones bacterianas
DE60225834D1 (de) Antibiotika-ge-81112-faktoren a, b, b1, pharmazeutisch unbedenkliche salze und zusammensetzungen sowie verwendungen davon
BRPI0416708A (pt) derivados de aminoquinazolidinadiona antibacterianos
DK1319666T3 (da) Hidtil ukendte antibakterielle forbindelser
AU2001281613A1 (en) Extracts from the fungus guignardia sp., their uses in pharmaceutical compositions, new isolate compound from the extract of the fungus guignardia sp. and its use in pharmaceutical compositions
WO2005007665A3 (en) Lincomycin derivatives possessing antibacterial activity
WO2002018353A3 (en) Oxazolidinone chemotherapeutic agents
BR0312550A (pt) Derivados de nocatiacina o-derivatizados
DK1439840T3 (da) Antibakterielle monobactam-forbindelser og fremgangsmåder til anvendelse heraf
MXPA01012427A (es) Antibioticos ge 23077, sales y composiciones farmaceuticamente aceptables y uso de los mismos.
AU2003259159A1 (en) N-aryl-2-oxazolidinones and their derivatives
WO2004108744A3 (en) Azalides and azaketolides having antimicrobial activity
WO2002018354A8 (en) Oxazolidinones and their use as antibacterial agents

Legal Events

Date Code Title Description
8364 No opposition during term of opposition